LNTH FY 2018 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$343M+3.6% YoY

Gross Profit

$175M50.9% margin

Operating Income

$64M18.8% margin

Net Income

$41M11.8% margin

EPS (Diluted)

$1.03

Cash Flow

Operating Cash Flow

$61M

Free Cash Flow

$41M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$440M

Total Liabilities

$369M

Stockholders' Equity

$71M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$343M	$331M	+3.6%
Gross Profit	$175M	$162M	+7.9%
Operating Income	$64M	$52M	+24.4%
Net Income	$41M	$123M	-67.2%